Table 2.
Summary of Harm Reduction Services to Offer in an ID Specialty Practice
| Recommendation | Purpose |
|---|---|
| Offer MOUD to those with OUD | Reduces HCV and HIV risk behaviors and ongoing transmission, improves HIV viral suppression, improves HCV cure and decreases reinfection risk, and reduces OD risk |
| Implement program for safe injection kit or safer equipment supply access | Avoid use of nonsterile equipment |
| Incorporate harm reduction–informed services before patient discharge/cessation of outpatient appointment | Educate patients on safe injection techniques and alternative equipment in the absence of preferred equipment or availability of safe injection kit |
| Screen for risk of HIV and offer PrEP and PEP as appropriate | Reduce HIV transmission rates |
| Assess underlying cause of IDU-associated infection | Adjust treatment for IDU-associated microbes |
| Offer and provide naloxone | Reduce OD |
| Develop relationship with nearest SSP | Connect PWID with readily available access to safer injection equipment |
Abbreviations: HCV, hepatitis C virus; ID, infectious diseases; IDU, injection drug use; MOUD, medications for opioid use disorder; OD, overdose; OUD, opioid use disorder; PEP, postexposure prophylaxis; PrEP, pre-exposure prophyalxis; PWID, people who inject drugs; SSP, syringe service program.